NDC 70436-025
bivalirudin
Bivalirudin
bivalirudin is a Intravenous Injection, Powder, Lyophilized, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Slate Run Pharmaceuticals, Llc. The primary component is Bivalirudin.
| Product ID | 70436-025_c44f8757-1a09-ab1e-e053-2a95a90a44e1 |
| NDC | 70436-025 |
| Product Type | Human Prescription Drug |
| Proprietary Name | bivalirudin |
| Generic Name | Bivalirudin |
| Dosage Form | Injection, Powder, Lyophilized, For Suspension |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2021-06-30 |
| Marketing Category | ANDA / |
| Application Number | ANDA213078 |
| Labeler Name | Slate Run Pharmaceuticals, LLC |
| Substance Name | BIVALIRUDIN |
| Active Ingredient Strength | 250 mg/1 |
| Pharm Classes | Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |